T. Hashimoto

662 total citations
23 papers, 479 citations indexed

About

T. Hashimoto is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, T. Hashimoto has authored 23 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in T. Hashimoto's work include Macrophage Migration Inhibitory Factor (4 papers), Diphtheria, Corynebacterium, and Tetanus (2 papers) and Antibiotic Resistance in Bacteria (2 papers). T. Hashimoto is often cited by papers focused on Macrophage Migration Inhibitory Factor (4 papers), Diphtheria, Corynebacterium, and Tetanus (2 papers) and Antibiotic Resistance in Bacteria (2 papers). T. Hashimoto collaborates with scholars based in Japan, Chile and South Korea. T. Hashimoto's co-authors include Yasuyuki Yamada, Kikuo Onozaki, Koh Miura, Hitoshi Umezawa, Hisayoshi Nakazawa, S Mitsuhashi, Yoshimi Homma, Mohamed Hamada, T Taniyama and T Kishimoto and has published in prestigious journals such as Journal of Applied Physiology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

T. Hashimoto

21 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Hashimoto Japan	11	210	135	89	58	45	23	479
R.D. Eichner Australia	11	223 1.1×	141 1.0×	130 1.5×	108 1.9×	45 1.0×	20	672
Reiko Tokuzen United Kingdom	11	178 0.8×	150 1.1×	64 0.7×	88 1.5×	64 1.4×	34	553
Yoshinori Tsuchiya Japan	10	143 0.7×	52 0.4×	82 0.9×	40 0.7×	61 1.4×	19	407
R. Toubiana France	13	154 0.7×	85 0.6×	61 0.7×	16 0.3×	81 1.8×	28	402
Ursula Wegner Germany	13	141 0.7×	94 0.7×	66 0.7×	92 1.6×	14 0.3×	21	542
Hisayoshi Akagawa Japan	13	169 0.8×	43 0.3×	180 2.0×	94 1.6×	23 0.5×	18	483
Ivan Bašić Croatia	17	143 0.7×	64 0.5×	75 0.8×	66 1.1×	25 0.6×	39	666
Susumu Yoshida Japan	12	238 1.1×	312 2.3×	55 0.6×	29 0.5×	24 0.5×	19	550
T Murayama Japan	12	126 0.6×	46 0.3×	179 2.0×	43 0.7×	39 0.9×	24	578
Chikako Takahashi Japan	11	160 0.8×	37 0.3×	48 0.5×	62 1.1×	40 0.9×	21	376

Countries citing papers authored by T. Hashimoto

Since Specialization

Citations

This map shows the geographic impact of T. Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Hashimoto more than expected).

Fields of papers citing papers by T. Hashimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Hashimoto. The network helps show where T. Hashimoto may publish in the future.

Co-authorship network of co-authors of T. Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of T. Hashimoto. A scholar is included among the top collaborators of T. Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Hashimoto. T. Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashimoto, T., et al.. (2021). P88.04 Successful Low-Dose Treatment for Patients with ROS1-Rearranged NSCLC who Developed Crizotinib-Related Heart Failure.. Journal of Thoracic Oncology. 16(3). S687–S687.

Okonogi, Noriyuki, T. Hashimoto, Masaya Ishida, et al.. (2012). Designed-seamless irradiation technique for extended whole mediastinal proton-beam irradiation for esophageal cancer. Radiation Oncology. 7(1). 173–173. 11 indexed citations

Hashimoto, T., Koichi Tokuuye, Kae Nemoto, et al.. (2005). Repeated Proton Beam Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 63. S159–S160. 1 indexed citations

Hashimoto, T., Shohei Shimizu, Yong Chan Ahn, et al.. (2004). Real-time monitoring of a digestive-tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors. International Journal of Radiation Oncology*Biology*Physics. 60(1). S414–S414. 1 indexed citations

Hashimoto, T. & Yasuyuki Yamada. (1994). Alkaloid Biogenesis: Molecular Aspects. Annual Review of Plant Physiology and Plant Molecular Biology. 45(1). 257–285. 194 indexed citations

Onozaki, Kikuo, Yukio Akiyama, A Okano, et al.. (1989). Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.. PubMed. 49(13). 3602–7. 52 indexed citations

Takeuchi, Akiteru, et al.. (1989). [Relationship between chemotaxis and surface antigen of neutrophils].. PubMed. 38(1). 31–5. 1 indexed citations

Nakazawa, Hisayoshi, T. Hashimoto, Tsuneo Nishiura, & S Mitsuhashi. (1983). Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections. Antimicrobial Agents and Chemotherapy. 24(3). 437–439. 4 indexed citations

Onozaki, Kikuo, Yukihiko Homma, Koh Miura, & T. Hashimoto. (1981). Scanning electron microscopic study of changes in the surfaces of lymphokine-treated guinea pig macrophages.. PubMed. 30(6). 471–81. 5 indexed citations

10.

Nakazawa, Hisayoshi, et al.. (1980). Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrobial Agents and Chemotherapy. 17(6). 908–911. 35 indexed citations

11.

Onozaki, Kikuo, et al.. (1980). Production of an antibody against guinea pig MIF. Cellular Immunology. 55(2). 465–475. 12 indexed citations

12.

Onozaki, Kikuo, Yoshimi Homma, & T. Hashimoto. (1979). Purification of an L-fucose binding lectin fromUlex europeus by affinity column chromatography. Cellular and Molecular Life Sciences. 35(12). 1556–1557. 3 indexed citations

13.

Onozaki, Kikuo, et al.. (1979). Production of an antibody against guinea pig MIF. Cellular Immunology. 48(2). 258–266. 17 indexed citations

14.

Hashimoto, T., et al.. (1977). [The general pharmacological actions of KW-1062, a new aminoglycoside antibiotic (author's transl)].. PubMed. 30(6). 362–85.

15.

Hashimoto, T., et al.. (1977). Effect of temperature on survival of Bacteroides fragilis subsp. fragilis and Escherichia coli in pus. Journal of Clinical Microbiology. 6(6). 567–570. 4 indexed citations

16.

Hashimoto, T., et al.. (1976). Effect of chilling on the survival of Bacteroides fragilis. Journal of Clinical Microbiology. 4(5). 432–436. 7 indexed citations

17.

Young, A. C., C. J. Martin, & T. Hashimoto. (1968). Can the distribution of inspired gas be altered?. Journal of Applied Physiology. 24(2). 129–134. 6 indexed citations

18.

Hashimoto, T., A. C. Young, & C. J. Martin. (1967). Compartmental analysis of the distribution of gas in the lungs.. Journal of Applied Physiology. 23(2). 203–209. 13 indexed citations

19.

Hara, Isao, Kiyoshi Sato, T. Hashimoto, et al.. (1965). STUDIES ON THE PREVENTIVE EFFECT OF KASUGAMYCIN ON RICE BLAST.. PubMed. 18. 115–9. 23 indexed citations

20.

Umezawa, Hitoshi, Mohamed Hamada, Yasuji Suhara, T. Hashimoto, & Tetsuro Ikekawa. (1965). Kasugamycin, a new antibiotic.. PubMed. 5. 753–7. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact